Bavarian Nordic A/S (BVNKF)
36.06
0.00 (0.00%)
USD |
OTCM |
Oct 13, 16:00
Bavarian Nordic Enterprise Value : 2.399B for Oct. 13, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 13, 2026 | 2.399B |
| October 12, 2026 | 2.399B |
| October 09, 2026 | 2.399B |
| October 08, 2026 | 2.399B |
| October 07, 2026 | 2.216B |
| October 06, 2026 | 2.216B |
| October 05, 2026 | 2.216B |
| October 02, 2026 | 2.216B |
| October 01, 2026 | 2.216B |
| September 30, 2026 | 2.216B |
| September 29, 2026 | 2.216B |
| September 28, 2026 | 2.134B |
| September 25, 2026 | 2.134B |
| September 24, 2026 | 2.134B |
| September 23, 2026 | 2.134B |
| September 22, 2026 | 2.134B |
| September 21, 2026 | 2.134B |
| September 18, 2026 | 2.134B |
| September 17, 2026 | 2.134B |
| September 16, 2026 | 2.134B |
| September 15, 2026 | 2.134B |
| September 14, 2026 | 2.134B |
| September 11, 2026 | 2.134B |
| September 10, 2026 | 2.134B |
| September 09, 2026 | 2.134B |
| Date | Value |
|---|---|
| September 08, 2026 | 2.134B |
| September 04, 2026 | 2.134B |
| September 03, 2026 | 2.134B |
| September 02, 2026 | 2.134B |
| September 01, 2026 | 2.134B |
| August 31, 2026 | 2.134B |
| August 28, 2026 | 2.134B |
| August 27, 2026 | 2.134B |
| August 26, 2026 | 2.134B |
| August 25, 2026 | 2.134B |
| August 24, 2026 | 2.134B |
| August 21, 2026 | 2.134B |
| August 20, 2026 | 1.763B |
| August 19, 2026 | 1.763B |
| August 18, 2026 | 1.763B |
| August 17, 2026 | 1.763B |
| August 14, 2026 | 1.763B |
| August 13, 2026 | 1.763B |
| August 12, 2026 | 1.763B |
| August 11, 2026 | 1.763B |
| August 10, 2026 | 1.763B |
| August 07, 2026 | 1.763B |
| August 06, 2026 | 1.763B |
| August 05, 2026 | 1.763B |
| August 04, 2026 | 1.763B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Evaxion AS | 16.12M |
| Genmab A/S | 25.60B |
| Ascendis Pharma A/S | 14.24B |
| Zealand Pharma A/S | 285.73M |
| Agenus, Inc. | 560.84M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 113.83M |
| Revenue (Quarterly) | 315.94M |
| Total Expenses (Quarterly) | 202.11M |
| EPS Diluted (Quarterly) | 1.498 |
| Gross Profit Margin (Quarterly) | 60.45% |
| Profit Margin (Quarterly) | 36.03% |
| Earnings Yield | 8.66% |
| Operating Earnings Yield | 5.72% |
| Normalized Earnings Yield | 8.363 |